Investment, Funding & Disinvestments

Solstice Oncology plans to begin enrolment in a Phase II clinical trial of porustobart in combination with pembrolizumab in the fourth quarter of 2026.

Encoded plans to use the proceeds primarily to fund a pivotal trial of ETX101 in infants and young children with SCN1A positive Dravet syndrome.

The acquisition brings MLM’s laboratory infrastructure and scientific expertise into Labcorp’s global network, creating a broader platform to support clinical trials across multiple regions.

Kerry will work with governments, development partners, multilateral institutions, civil society and the private sector to advocate for stronger health systems and more sustainable health financing.

The Al Ain Service Centre will provide a range of services covering counselling and guidance, protective care, alternative care, empowerment and awareness programmes, and custody visitation.

The facility expands Nimba County’s cold chain capacity and is designed to keep vaccines safe and effective from storage and transportation to delivery at health facilities and communities.

The investments will focus on improving primary healthcare, expanding access to essential services and strengthening the country’s ability to respond to public health emergencies.

The FDA approval covers both children and adults living with Alexander disease, providing a treatment option that targets the underlying cause rather than focusing solely on symptoms.

The company reported group sales of EUR 883 million (US$1.03 billion), representing a 7 percent increase from the same period in 2025.

The 72,300 square foot facility is the largest single site contract development and manufacturing organisation (CDMO) facility in North America dedicated to radiopharmaceutical development, according to AtomVie.